CWC15

Spliceosome-associated protein CWC15 homolog · Q9P013 · CWC15 on Sugi Atlas →

0 patent compounds predicted against CWC15, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to CWC15 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Fludarabine With or Without Cyclophosphamide in Treating Patients With Chronic Lymphocytic Leukemia PHASE3COMPLETED
Mobilization and Collection of Peripheral Blood Stem Cells in Patients With Fanconi Anemia Using G-CSF and AMD3100 PHASE1/PHASE2COMPLETED
Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Gastric Cancer PHASE1/PHASE2COMPLETED
Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Esophageal Cancer PHASE1COMPLETED
Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Gastric Cancer PHASE1COMPLETED
Aberrant Splicings Due to Microsatellite Instability in Colorectal Cancer : Physiopathological and Clinical Impact nanUNKNOWN
Identifying Genes and Mutations Underlying Retinitis Pigmentosa and Allied Diseases nanUNKNOWN
Maternal Genes and Epimutations: Beckwith-Wiedemann Syndrome & Reproductive Risks nanRECRUITING
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING
PCD New Gene Discovery nanCOMPLETED
Biocollection in MyeloDysplastic Syndrome (P-MDS) nanRECRUITING
The Value of circRNAs (hsa_circ_0004001) in Early Diagnosis of HCC nanUNKNOWN
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic nanCOMPLETED
Study of Constitutional Platelet Disease nanUNKNOWN
Identification of New Genes Implicated in Rare Neurosensory Diseases by Whole Exome Sequencing nanUNKNOWN
Diagnosis of Primary Ciliary Dyskinesia nanCOMPLETED
Genetics of Primary Ciliary Dyskinesia nanCOMPLETED
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Novel Genetic Disorders of the Immune System nanRECRUITING
Whole-genome Sequencing Study in Patients With Diminished Ovarian Reserve nanUNKNOWN
Endoplasmic Reticulum Stress and Resistance to Treatments in Ph-negative Myeloproliferative Neoplasms nanCOMPLETED
Patient's Derived Organoids for Drug Screening in Glioblastoma nanNOT_YET_RECRUITING
Classification, Functional Stratification and Biomarkers in Ciliopathy (CILLICORIRCM) nanCOMPLETED
Developing a Pipeline to Employ RNA-Seq as a Complementary Diagnostic Tool in Rare Diseases nanRECRUITING
Mesenchymal Stem Cells in NPM1 Mutated Low Risk Acute Myeloid Leukemia: a Study of the Tumor Microenvironment and Its Contribution to the Outcome nanCOMPLETED
NICUSeq: A Trial to Evaluate the Clinical Utility of Human Whole Genome Sequencing (WGS) Compared to Standard of Care in Acute Care Neonates and Infants nanCOMPLETED
Pathogenesis of Primary Ciliary Dyskinesia (PCD) Lung Disease nanRECRUITING
Identification of New FTLD Genes nanUNKNOWN
CADASIL Disease Discovery nanCOMPLETED
Whole Exome and Whole Genome Sequencing for Genotyping of Inherited and Congenital Eye Conditions nanRECRUITING

Related proteins — ESM-2 sequence neighbours (a CWC15 binder may also engage these)

ProteinNameSimilarity
Q5BJP2 1.000 Q5BJP2 →
Q9JHS9 1.000 Q9JHS9 →
Q5RE65 1.000 Q5RE65 →
Q2KJD3 1.000 Q2KJD3 →
Q6NUB2 1.000 Q6NUB2 →
Q0VFP5 1.000 Q0VFP5 →
Q6DKE6 1.000 Q6DKE6 →
Q6IQU4 1.000 Q6IQU4 →
Q5B020 0.999 Q5B020 →
O45766 0.992 O45766 →
Q3TQI7 0.991 Q3TQI7 →
Q9NZ63 0.984 Q9NZ63 →
Q9V3B6 0.983 Q9V3B6 →
Q5RC87 0.982 Q5RC87 →
Q1RMM1 0.982 Q1RMM1 →
Q7RZK5 0.981 Q7RZK5 →
Q4WPM6 0.981 Q4WPM6 →
Q803J8 0.981 Q803J8 →
O08837 0.981 O08837 →
Q6PII3 0.980 Q6PII3 →
Q2KJC1 0.980 Q2KJC1 →
Q6U6G5 0.980 Q6U6G5 →
Q6A068 0.980 Q6A068 →
Q5BC69 0.979 Q5BC69 →
Q521C0 0.979 Q521C0 →
Q8GX84 0.979 Q8GX84 →
CDC5L Cell division cycle 5-like protein 0.979 landscape →
Q4IRI9 0.979 Q4IRI9 →
A4IGY3 0.978 A4IGY3 →
P92948 0.978 P92948 →